Analyst Ratings for Pacific Biosciences of California (pacb)

pacb Rating Summary

pacb Price Target Summary

* Over Last 12-Mos
  |   Expand Research on pacb
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $9.75 (+6.4%) * Over Last 12-Mos
Rating Score: 4.2 / 10   Percentile Rank: 43%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
4/15/2016 First Analysis New Coverage Overweight
(N/A)
11.00
(N/A)
8.74 9.16 4.81% Details
2/4/2016 Piper Jaffray Downgrade Neutral
(Overweight)
11.00
(9.00)
12.37 9.16 -25.95% Details
Like PACB Ratings? Also take a look at RHHBY, SFLY, GSK, RMBS

PACB Ratings News